SIGNIFICANT ACCOUNTING POLICIES, Part 2 (Details) - USD ($)			3 Months Ended		9 Months Ended		12 Months Ended
	Jan. 03, 2020	Jun. 03, 2008	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Sep. 30, 2020	Jun. 18, 2019	Jun. 19, 2014	Sep. 22, 2011
Stock options, additional disclosure [Abstract]
Granted, aggregate intrinsic value					$ 0
Forfeited/expired/cancelled, aggregate intrinsic value					0
Outstanding, aggregate intrinsic value, end of period			$ 0		0
Exercisable, aggregate intrinsic value, end of period			0		$ 0
Stock Options Outstanding [Abstract]
Number of Shares (in shares)								950,997
Average remaining contract term					5 years 4 months 24 days
Weighted average exercise price (in dollars per share)								$ 4.09
Aggregate intrinsic value			0		$ 0			$ 0
Stock Options Exercisable [Abstract]
Number of Shares (in shares)								205,583
Weighted average exercise price (in dollars per share)								$ 7.59
Aggregate intrinsic value			0		0			$ 0
Total fair value of stock options vested during period	$ 943,126
Employee Service Share-based Compensation, Aggregate Disclosures [Abstract]
Allocated share-based compensation expense			477,204	$ 506,588	824,345	$ 1,230,966
1 to 2.79999 [Member]
Stock options, additional disclosure [Abstract]
Outstanding, aggregate intrinsic value, end of period			0		0
Exercisable, aggregate intrinsic value, end of period			0		$ 0
Range of Exercise Prices [Abstract]
Range of exercise prices, minimum (in dollars per share)					$ 1
Range of exercise prices, maximum (in dollars per share)					$ 2.79999
Stock Options Outstanding [Abstract]
Number of Shares (in shares)								636,364
Average remaining contract term					6 years 5 months 15 days
Weighted average exercise price (in dollars per share)								$ 2.36
Aggregate intrinsic value			0		$ 0			$ 0
Stock Options Exercisable [Abstract]
Number of Shares (in shares)								0
Weighted average exercise price (in dollars per share)								$ 0
Aggregate intrinsic value			0		0			$ 0
2.8 to 4.59999 [Member]
Stock options, additional disclosure [Abstract]
Outstanding, aggregate intrinsic value, end of period			0		0
Exercisable, aggregate intrinsic value, end of period			0		$ 0
Range of Exercise Prices [Abstract]
Range of exercise prices, minimum (in dollars per share)					$ 2.8
Range of exercise prices, maximum (in dollars per share)					$ 4.59999
Stock Options Outstanding [Abstract]
Number of Shares (in shares)								0
Average remaining contract term					0 years
Weighted average exercise price (in dollars per share)								$ 0
Aggregate intrinsic value			0		$ 0			$ 0
Stock Options Exercisable [Abstract]
Number of Shares (in shares)								0
Weighted average exercise price (in dollars per share)								$ 0
Aggregate intrinsic value			0		0			$ 0
4.6 to 6.39999 [Member]
Stock options, additional disclosure [Abstract]
Outstanding, aggregate intrinsic value, end of period			0		0
Exercisable, aggregate intrinsic value, end of period			0		$ 0
Range of Exercise Prices [Abstract]
Range of exercise prices, minimum (in dollars per share)					$ 4.6
Range of exercise prices, maximum (in dollars per share)					$ 6.39999
Stock Options Outstanding [Abstract]
Number of Shares (in shares)								59,883
Average remaining contract term					3 years 5 months 1 day
Weighted average exercise price (in dollars per share)								$ 5.56
Aggregate intrinsic value			0		$ 0			$ 0
Stock Options Exercisable [Abstract]
Number of Shares (in shares)								30,000
Weighted average exercise price (in dollars per share)								$ 5.51
Aggregate intrinsic value			0		0			$ 0
6.4 to 8.19999 [Member]
Stock options, additional disclosure [Abstract]
Outstanding, aggregate intrinsic value, end of period			0		0
Exercisable, aggregate intrinsic value, end of period			0		$ 0
Range of Exercise Prices [Abstract]
Range of exercise prices, minimum (in dollars per share)					$ 6.4
Range of exercise prices, maximum (in dollars per share)					$ 8.19999
Stock Options Outstanding [Abstract]
Number of Shares (in shares)								207,875
Average remaining contract term					3 years 3 months 18 days
Weighted average exercise price (in dollars per share)								$ 7.31
Aggregate intrinsic value			0		$ 0			$ 0
Stock Options Exercisable [Abstract]
Number of Shares (in shares)								147,458
Weighted average exercise price (in dollars per share)								$ 7.28
Aggregate intrinsic value			0		0			$ 0
8.2 to 12 [Member]
Stock options, additional disclosure [Abstract]
Outstanding, aggregate intrinsic value, end of period			0		0
Exercisable, aggregate intrinsic value, end of period			0		$ 0
Range of Exercise Prices [Abstract]
Range of exercise prices, minimum (in dollars per share)					$ 8.2
Range of exercise prices, maximum (in dollars per share)					$ 12
Stock Options Outstanding [Abstract]
Number of Shares (in shares)								46,875
Average remaining contract term					2 years 10 months 6 days
Weighted average exercise price (in dollars per share)								$ 11.45
Aggregate intrinsic value			0		$ 0			$ 0
Stock Options Exercisable [Abstract]
Number of Shares (in shares)								28,125
Weighted average exercise price (in dollars per share)								$ 11.45
Aggregate intrinsic value			$ 0		$ 0			$ 0
Stock Options [Member]
Share-based Arrangements with Employees and Nonemployees [Abstract]
Number of stock options expired, forfeited or exercised under the plan (in shares)					358,127
Number of stock options outstanding under the plan (in shares)			950,997		950,997		642,625	950,997
Assumptions made in calculating fair values of options [Abstract]
Expected term					6 years 3 months 18 days
Expected volatility					45.37%
Expected dividend yield					0.00%
Risk-free interest rate					1.33%
Stock options, number of shares [Roll forward]
Outstanding, beginning of period (in shares)					642,625
Granted (in shares)					702,499
Exercised (in shares)					(36,000)
Forfeited/expired/cancelled (in shares)					(358,127)
Outstanding, end of period (in shares)			950,997		950,997		642,625
Exercisable, end of period (in shares)			205,583		205,583
Stock options, outstanding, weighted average exercise price per share [Roll Forward]
Outstanding, beginning of period (in dollars per share)					$ 5.79
Granted (in dollars per share)					2.50
Exercised (in dollars per share)					6.30
Forfeited/expired/cancelled (in dollars per share)					2.44
Outstanding, end of period (in dollars per share)			$ 4.09		4.09		$ 5.79
Exercisable, end of period (in dollars per share)			$ 7.59		$ 7.59
Stock options, additional disclosure [Abstract]
Outstanding, weighted average remaining contract term					5 years		3 years
Exercisable, weighted average remaining contract term					3 years
Outstanding, aggregate intrinsic value, beginning of period					$ 285,925
Exercised, aggregate intrinsic value					95,976
Outstanding, aggregate intrinsic value, end of period			$ 0		0		$ 285,925
Exercisable, aggregate intrinsic value, end of period			0		0
Stock Options Outstanding [Abstract]
Aggregate intrinsic value			0		0		$ 285,925	$ 0
Stock Options Exercisable [Abstract]
Aggregate intrinsic value			$ 0		$ 0			0
Net unrecognized compensation cost								775,947
Weighted average period for recognition of net unrecognized compensation cost					2 years 4 months 6 days
Total fair value of stock options vested during period					$ 172,145	295,412
Weighted Average Grant Date Fair Value [Abstract]
Weighted average period for recognition of net unrecognized compensation cost					2 years 4 months 6 days
Restricted Stock and Restricted Stock Units [Member]
Stock Options Exercisable [Abstract]
Weighted average period for recognition of net unrecognized compensation cost					1 year 11 months 8 days
Number of Shares & Units [Abstract]
Outstanding, beginning of period (in shares)					545,986
Granted (in shares)					642,081
Vested (in shares)					(66,728)
Forfeited/expired/cancelled (in shares)					(486,488)
Outstanding, end of period (in shares)			634,851		634,851		545,986
Weighted Average Grant Date Fair Value [Abstract]
Outstanding, beginning of period (in dollars per share)					$ 7.47
Granted (in dollars per share)					2.68
Vested (in dollars per share)					3.62
Forfeited/expired/cancelled (in dollars per share)					6.43
Outstanding, end of period (in dollars per share)			$ 3.43		$ 3.43		$ 7.47
Net unrecognized compensation cost								$ 1,391,802
Weighted average period for recognition of net unrecognized compensation cost					1 year 11 months 8 days
2008 Stock Incentive Plan [Member] | Stock Options [Member]
Share-based Arrangements with Employees and Nonemployees [Abstract]
Number of shares authorized under the plan (in shares)		625,000									750,000
Increase in number of shares authorized (in shares)		125,000
Number of stock options expired, forfeited or exercised under the plan (in shares)					694,000
Number of stock options outstanding under the plan (in shares)			56,000		56,000			56,000
Options or shares still available to be issued (in shares)								0
Stock options, number of shares [Roll forward]
Forfeited/expired/cancelled (in shares)					(694,000)
Outstanding, end of period (in shares)			56,000		56,000
2014 Stock Incentive Plan [Member] | Stock Options [Member]
Share-based Arrangements with Employees and Nonemployees [Abstract]
Number of shares authorized under the plan (in shares)										800,000
Number of stock options expired, forfeited or exercised under the plan (in shares)					479,375
Number of stock options outstanding under the plan (in shares)			299,564		299,564			299,564
Options or shares still available to be issued (in shares)								0
Stock options, number of shares [Roll forward]
Forfeited/expired/cancelled (in shares)					(479,375)
Outstanding, end of period (in shares)			299,564		299,564
2019 Omnibus Incentive Plan [Member] | Stock Options [Member]
Share-based Arrangements with Employees and Nonemployees [Abstract]
Number of shares authorized under the plan (in shares)									2,400,000
Number of stock options expired, forfeited or exercised under the plan (in shares)					489,294
Number of stock options outstanding under the plan (in shares)			1,230,286		1,230,286			1,230,286
Options or shares still available to be issued (in shares)								1,311,096
Number of stock options forfeited under the plan (in shares)			83,127		123,127
Stock options, number of shares [Roll forward]
Forfeited/expired/cancelled (in shares)					(489,294)
Outstanding, end of period (in shares)			1,230,286		1,230,286
2019 Omnibus Incentive Plan [Member] | Restricted Shares [Member]
Share-based Arrangements with Employees and Nonemployees [Abstract]
Number of stock options expired, forfeited or exercised under the plan (in shares)			16,314		486,488
Stock options, number of shares [Roll forward]
Forfeited/expired/cancelled (in shares)			(16,314)		(486,488)
Cost of Product Sales [Member]
Employee Service Share-based Compensation, Aggregate Disclosures [Abstract]
Allocated share-based compensation expense			$ 0	2,691	$ 6,300	8,479
Research and Development Expenses [Member]
Employee Service Share-based Compensation, Aggregate Disclosures [Abstract]
Allocated share-based compensation expense			126,333	56,251	281,070	172,346
Selling, General and Administrative Expenses [Member]
Employee Service Share-based Compensation, Aggregate Disclosures [Abstract]
Allocated share-based compensation expense			350,871	447,646	960,959	1,050,141
Severance and Related Costs [Member]
Employee Service Share-based Compensation, Aggregate Disclosures [Abstract]
Allocated share-based compensation expense			$ 0	$ 0	$ (423,984)	$ 0